Dublin, CA, United States of America

Dharmaraj Samuel

This inventor holds 2 USPTO granted patents. Top assignees: Pfizer Corporation, University of California. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dharmaraj Samuel. Retrieved from https://idiyas.com/inventor/dharmaraj-samuel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dharmaraj Samuel: Innovator in Cancer Treatment

Introduction

Dharmaraj Samuel is a notable inventor based in Dublin, CA, who has made significant contributions to the field of cancer treatment. With a focus on innovative methods utilizing antibodies, he has been awarded 2 patents for his groundbreaking work.

Latest Patents

Samuel's latest patents include a method of treating cancer using anti-AV8 antibodies. This invention provides antibodies and antigen-binding fragments that specifically bind to αvβ8 integrin. The invention encompasses various uses and associated methods of employing these antibodies. Another significant patent is for anti-AVB8 antibodies and compositions, which also specifically bind to αvβ8 integrin, including their uses and methods.

Career Highlights

Throughout his career, Dharmaraj Samuel has worked with prominent organizations such as Pfizer Corporation and the University of California. His experience in these institutions has allowed him to develop and refine his innovative approaches to cancer treatment.

Collaborations

Some of his notable coworkers include Kyle Steven Niessen and Charles Ray Holst, who have collaborated with him on various projects.

Conclusion

Dharmaraj Samuel's contributions to cancer treatment through his patented inventions highlight his role as a leading innovator in the field. His work continues to inspire advancements in medical research and treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…